Optimal Management of Vascular Disease 2014: Current Concepts and Controverseries

April 24 – 26, 2014
Taj Hotel
Boston, MA



This course is intended to provide an in-depth examination of a spectrum of topics related to the management of patients with vascular disease. A comprehensive review of existing data as well as new information regarding the natural history, pathogenesis, diagnosis and treatment of commonly encountered vascular problems will be presented by an outstanding faculty of over 40 nationally recognized authorities leading to a better understanding of contemporary standards of effective and cost-efficient care as well as future trends in vascular surgery.

The wide scope of this course allows the faculty to provide current updates and advances in many areas of vascular surgery and to indicate the advantages and possible disadvantages of varying methods of management for a wide variety of problems in vascular surgery.

By providing up to date information and data on current therapies, the course will improve clinicians' competence, performance and patient outcomes.

By encouraging active audience participation and a panel session at the conclusion of each session of the course, we can solidify factual knowledge and clarify proper indications for use of different treatment modalities.

The teaching modalities in this course include: didactic lectures, panel discussions, question and answer sessions, video demonstrations, and group case discussions.

LEARNING OBJECTIVES

Care of vascular diseases is undergoing rapid change, with much new knowledge and shifts in therapies toward less invasive treatments. The proper role of such new treatments, and their use in place of more traditional open surgical interventions, remains highly controversial. This course is aimed at addressing such controversies and clarifying the clinical circumstances most appropriate for different treatments and interventions.

Upon completion of this course, participants will be able to:

  • Describe the indications for intervention in carotid artery disease
  • Improve clinical decision-making regarding appropriate interventions for carotid endarterectomy
  • Determine the advantages and disadvantages of carotid stenting
  • Evaluate the best available options for treating lower extremity ischemia
  • Utilize endovascular therapies for peripheral artery occlusive disease as appropriate
  • Manage acute arterial ischemia according to current Society for Vascular Surgery guidelines
  • Apply the current guidelines for aortic aneurysm management
  • Provide care for venous disease in keeping with recent evidence and recommendations

WHO SHOULD ATTEND

The target audience for the course includes vascular, general or cardiothoracic surgeons, as well as interventional radiologists or cardiologists treating vascular diseases. In addition, nurse practitioners or other allied health providers involved in the diagnosis and management of vascular disease will benefit from the broad coverage of the course. Residents and Fellows in training are welcome to attend.

ACCREDITATION

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Harvard Medical School designates this live activity for a maximum of 19.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credits™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©), therefore up to 19.5 ECMEC© Credits are available. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

PROGRAM SCHEDULE*

THURSDAY, APRIL 24, 2014
7:00 Registration
7:20 Welcome and Introductory Remarks
SESSION I: CEREBROVASCULAR DISEASE
7:30 Can we predict stroke risk in individual patients?
Dr. William Mackey
7:45 Is contralateral stenosis or occlusion a significant risk for CEA?
Dr. Virendra Patel
8:00 What is the role of carotid stenting? A surgeon's perspective Dr. Bruce Perler
8:15 Open surgical cervical approach with flow reversal for carotid stenting:
Is it a better way?
Dr. Chris Kwolek
GREAT DEBATE
8:30 Patients with asymptomatic carotid stenosis should
be treated by modern best medical therapy
Dr. Lee Schwamm
8:45 Are you kidding? CEA remains the best for significant
asymptomatic carotid stenosis
Dr. Richard Cambria
9:00 Panel Discussion/Questions
9:30 BREAK – PLEASE VISIT EXHIBITS
SESSION II: LOWER EXTREMITY OCCLUSIVE DISEASE
10:00

Can treatment with drugs or exercise programs for claudication give outcomes comparable to interventional procedures?
Dr. Michael Jaff

10:15 What is the best strategy for infrainguinal bypass if the saphenous vein
is inadequate or unavailable?
Do heparin-bonded prosthetic grafts have a role?
Dr. Jeb Hallett
10:30 Can drug-eluting stents or covered stent grafts improve
results of L.E. endovascular therapy?
Dr. Alik Farber
10:45 What is the impact of failed L.E. endovascular therapy?
Do you burn bridges?
Dr. Glenn LaMuraglia
11:00 What are the indications for lower extremity bypass grafts
in the endovascular era?
Dr. Bruce Perler
11:15 Panel Discussion/Questions
11:45 LUNCH (ON YOUR OWN) – PLEASE VISIT EXHIBITS
SESSION III: ANEURYSMAL DISEASE
1:00 Can AAA rupture risk be predicted?
Dr. Elliot Chaikof
1:15 How I select an endovascular stent graft for EVAR
Dr. Clem Darling
1:30 Chimney and Snorkel grafts as an adjunct to EVAR
Dr. Andres Schanzer
1:45 Technical tips for open juxtarenal AAA repair:
Getting better results than complex endovascular procedures
Dr. Glenn LaMuraglia
2:00 What's on the horizon for endovascular procedures for aneurysmal disease?
Dr. Chris Kwolek
2:15 Panel Discussion/Questions
2:45 BREAK – PLEASE VISIT EXHIBITS
SESSION IV: VASCULAR EMERGENCIES
3:15 Acute lower extremity ischemia
Dr. Raul Guzman
3:30 Early neurologic deficit following CEA
Dr. Frank Pomposelli
3:45 Acute mesenteric ischemia
Dr. Todd Lancaster
4:00 Tips for open repair of ruptured AAA
Dr. Darrin Clouse
4:15 EVAR for ruptured AAA: Is it a better way?
Dr. Clem Darling
4:30 Acute iliofemoral venous thrombosis with phlegmasia
Dr. Mickey Meier
4:45 Vascular Trauma: exposures, control and potential
use of endovascular therapies
Dr. Jeffrey Kalish
5:00 Panel Discussion/Questions
5:30 ADJOURN
FRIDAY, APRIL 25, 2014
SESSION V: CONTEMPORARY TREATMENT OF VENOUS DISEASE
7:30 How to select patients for endo-venous therapies:
what work-up do you need?
Dr. Sherry Scovell
7:40 Saphenous vein ablation: methods and results
Dr. Sherry Scovell
7:55 Updates on foam sclerotherapy and ambulatory phlebectomy
Dr. Nancy Cantelmo
8:15 SVS/AVF guidelines for management of venous ulcers
Dr. Thomas O'Donnell
8:30 Updates on current management of DVT
Dr. Robert Schainfeld
8:45 Panel Discussion/Questions
9:15 BREAK – PLEASE VISIT EXHIBITS
SESSION VI: UPDATES IN VASCULAR SURGERY
9:45 Tips for contemporary wound care: Is wet to dry passe?
Dr. Michael Watkins
10:00 Optimal strategies for ESRD hemodialysis access
Dr. Alik Farber
10:15 Management of dialysis access failures
Dr. Todd Lancaster
10:30 Do type II endoleaks after EVAR require treatment?
If so, how best to best do it?
Dr. Mark Conrad
10:45 Panel Discussion/Questions
11:15 Linton Lecture (Introduction: Dr. Richard Cambria)
Dr. David Brewster
12:00 LUNCH (ON YOUR OWN) – PLEASE VISIT EXHIBITS
SESSION VII: CURRENT CONTROVERSIES
1:15 When should popliteal aneurysms be treated? Is there a role for stent grafts?
Dr. Matt Menard
1:30 What is the role of renal artery intervention in current practice?
Dr. Joseph Garasic
1:45 Management of acute aortic dissection: Does TEVAR have a place?
Dr. Mark Conrad
2:00 Is tibial occlusive disease with critical limb ischemia
best managed by bypass or endovascular therapy?
Dr. Michael Belkin
2:15 Panel Discussion/Questions
2:45 BREAK – PLEASE VISIT EXHIBITS
SESSION VIII: CHALLENGING PROBLEMS
3:15 Unusual carotid artery problems: Carotid body tumors, carotid dissection,
FMD/aneurysms and Takayasu's arteritis
Dr. Jeb Hallett
3:30 Tips for management of difficult groin wound problems
Dr. Darrin Clouse
3:45 Treatment of vascular complications of thoracic outlet syndrome
Dr. Louis Nguyen
4:00 VASCULAR ROUNDS
Dr. Elizabeth Blazick, Dr. Clay Brinster

PROBLEM CASE PRESENTATIONS
Moderator: Dr. David Brewster
Panelists: Dr. Richard Cambria, Dr. Clem Darling,
Dr. Jeb Hallett, Dr. Mickey Meier, Dr. Mark Iafrati
5:30 ADJOURN
SATURDAY, APRIL 26, 2014
SESSION IX: HOW I DO IT (VIDEO SESSION I)
7:30 How I do venous ablation procedures
Dr. Sherry Scovell
7:45 How I do spine exposures for orthopaedic procedures
Dr. Virendra Patel
8:00 How I do femoropopliteal bypass
Dr. Elias Arous
8:15 Tips for successful femoro-tibial bypass
Dr. David Campbell
8:30 How to get exposure for juxtarenal and suprarenal aortic surgery
Dr. Richard Cambria
9:00 Panel Discussion/Questions
9:30 BREAK – PLEASE VISIT EXHIBITS
SESSION X: HOW I DO IT (VIDEO SESSION II)
10:00 How I treat May-Thurner Syndrome
Dr. Chieh-Min Fan
10:15 How to do IVC filter insertion and removal
Dr. James Estes
10:30 How I do carotid stents
Dr. Chris Kwolek
10:45 How to successfully treat chronic total occlusions (TCO)
Dr. Mohammed Eslami
11:00 Utility of mechanical thrombectomy devices for arterial and venous occlusions Dr. Mickey Meier
11:15 How I do EVAR for ruptured AAA: step by step protocol
Dr. Clem Darling
11:30 Panel Discussion/Questions
12:00 COURSE CONCLUDES
Meeting Adjourned

*Program changes/substitutions may be made without notice.

REGISTRATION INFORMATION



Class Number #342510

Tuition Fees:
Physicians: $675 (USD)
Residents and Fellows in Training: $300 (USD)
Allied Health Professionals: $300 (USD)

PAYMENT INFORMATION

All foreign payments must be made by a draft on a United States Bank or by AMEX, Visa or MasterCard.

If paying by check (draft on a United States bank), please make payable to Harvard Medical School and mail with registration form to Harvard Medical School - Department of Continuing Education, PO Box 417476, Boston, MA 02241-7476. Telephone or fax registration is not accepted. Registration with cash payment is not permitted.

If paying by credit card, please register online.

Telephone, fax or mail-in registration with credit card payment is not accepted.

Inquiries should be directed to the above address, made by phone: (617) 384‑8600, Monday ‑ Friday, 10 AM to 4 PM (EST), or by email: hms‑cme@hms.harvard.edu

Upon receipt of your registration form an email confirmation from the HMS-DCE office will be sent to you. Therefore, be sure to include an email address that you check daily/frequently. Your email address is used for critical information about the course including: registration confirmation, course evaluation and certificate.

ACGME COMPETENCIES

This course is designed to meet one or more of the following Accreditation Council of Graduate Medical Education competencies:

  • Medical knowledge
  • Practice-Based Learning and Improvement

DISCLOSURE POLICY

Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

TUITION REFUND POLICY

A handling fee of $60 is deducted for cancellation. Refund requests must be received by postal mail, email or fax one week prior to this activity. No refunds will be made thereafter.

COURSE LOCATION

All sessions for this course will be held in the Taj Hotel, 15 Arlington Street, Boston, MA 02116 (Telephone: 617-536-5700 or 1-877-482-5267.

Please note that there are several events taking place in the Boston area the week of April 20th and hotel rooms will likely be at a premium. We encourage you to book your accommodations as early as possible.

ACCOMMODATIONS/TRAVEL

A limited number of rooms have been reserved at the Taj Boston (617-536-5700) until March 26, 2014. Please specify that you are enrolled in this course to receive the reduced room rate of $325 single/double. Please do not purchase non-refundable airline ticket(s) until you have recieved an email from our office confirming your paid registration. For airfare reservations contact the HMS Travel Desk toll free 1-877-4-HARVMD (1-877-442-7863) Monday - Friday 9 am to 8 pm (EST). From outside the U.S., Canada and Virgin Islands, please call (617) 599-3764.



Course #342510





Offered by


Division of Vascular
and Endovascular Surgery

Course Directors
David C. Brewster, MD
Glenn M. LaMuraglia, MD

No time to register now? Add your name to the mailing list to receive future notices about this course!



FACULTY

Elias J. Arous, M.D.
University of Massachusetts
Medical Center

Michael Belkin, M.D.

Brigham and Women's Hospital

Elizabeth Blazick, M.D.

Massachusetts General Hospital

David C. Brewster, M.D.

Massachusetts General Hospital

Clayton Brinster, M.D.

Massachusetts General Hospital

Richard P. Cambria, M.D.

Massachusetts General Hospital

David R. Campbell, M.D.

Beth Israel Deaconess Medical Center and Joslin Diabetes Center

Nancy L. Cantelmo, M.D.

Massachusetts General Hospital

Elliot Chaikof, M.D.

Beth Israel Deaconess
Medical Center

W. Darrin Clouse, M.D.

University of California-Davis
Medical Center

Mark F. Conrad, M.D.

Massachusetts General Hospital

R. Clement Darling III, M.D.

The Vascular Group, Albany NY

Mohammed Eslami, M.D.

Boston Medical Center

James M. Estes, M.D.

Tufts Medical Center

Chieh-Min Fan, M.D.

Brigham and Women's Hospital

Alik Farber, M.D.

Boston Medical Center

Joseph Garasic, M.D.

Massachusetts General Hospital

Raul J. Guzman, M.D.

Beth Israel Deaconess
Medical Center

John (Jeb) W. Hallett, Jr., M.D.

Roper Saint Francis Heart
and Vascular Center

Mark D. Iafrati, M.D.

Tufts Medical Center

Michael Jaff, D.O.

Massachusetts General Hospital

Jeffrey A. Kalish, M.D.

Boston Medical Center

Christopher J. Kwolek, M.D.

Massachusetts General Hospital

Glenn M. LaMuraglia, M.D.

Massachusetts General Hospital

Robert T. Lancaster, M.D.

Massachusetts General Hospital

William C. Mackey, M.D.

Tufts Medical Center

George H. Meier, M.D.

University of Cincinnati

Matthew T. Menard, M.D.

Brigham and Women's Hospital

Louis L. Nguyen, M.D.

Brigham and Women's Hospital

Thomas F. O'Donnell, M.D.

Tufts Medical Center

Virendra I. Patel, M.D.

Massachusetts General Hospital

Bruce A. Perler, M.D., M.B.A.

The Johns Hopkins Hospital

Frank B. Pomposelli, M.D.

Saint Elizabeth's Medical Center

Robert M. Schainfeld, M.D.

Massachusetts General Hospital

Andres Schanzer, M.D.

University of Massachusetts
Medical Center

Lee H. Schwamm, M.D.

Massachusetts General Hospital

Sherry D. Scovell, M.D.

Massachusetts General Hospital

Michael T. Watkins, M.D.

Massachusetts General Hospital

 

  Copyright © 2014, Harvard Medical School, Department of Continuing Education
    Last update 1.23.2014